SynopsisIndoximod, a methylated tryptophan, acts as an IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, and reverses IDO-mediated immune suppression. The global Indoximod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2.....
SynopsisEpacadostat is a potent and selective indoleamine 2,3-dioxygenase (IDO1) inhibitor. The global Epacadostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-20.....
SynopsisErianin, a natural product derived from Dendrobium chrysotoxum, has been used as an analgesic in traditional Chinese medicine and is a potential anti-tumor agent. Erianin can inhibit IDO-induced tumor angiogenesis. The global Erianin market was valued at.....
SynopsisCoptisin chloride is an MAO-A inhibitor. Coptisin chloride is a bacterial collagenase inhibitor. The global Coptisine Chloride market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the for.....
SynopsisApocynin is a compound isolated from the traditional medicinal plant P. kurroa and structurally related to vanillin that acts as an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. The global Apocynin market was valued a.....
SynopsisZanubrutinib is a potent and covalent inhibitor of Bruton's tyrosine kinase. The global Zanubrutinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
SynopsisPimecrolimus is a natural ascomycin macrolactam that binds to macrophilin-12 and inhibits calcineurin as well as prolyl isomerase. The global Pimecrolimus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessin.....
SynopsisTenoxicam is a non-steroidal anti-inflammatory drug (NSAID) that acts as a COX inhibitor. The global Tenoxicam market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 202.....
SynopsisDemethylzeylasteral, the active component isolated from Tripterygium wilfordii Hook F., inhibits UDP-glucuronosyltransferase (UGT) isoforms UGT1A6 and UGT2B7 with immunosuppressive effects. The global Demethylzeylasteral market was valued at US$ million .....
SynopsisBendazac is an anticataract drug. It has been reported that Bendazac acts by preventing protein denaturation. The global Bendazac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the .....
